Pharmacokinetics of oltipraz and its major metabolite (RM) in patients with liver fibrosis or cirrhosis: relationship with suppression of circulating TGF-beta1.

Source:http://linkedlifedata.com/resource/pubmed/id/20664537

Download in:

View as

General Info

PMID
20664537